BCS Stock Analysis: Barclays | NYSE
Banks - Diversified | NYSE, USA | Market Cap: 92.654m USD | 12M Return: 49.4% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 123M
EPS Trend: 74.8%
Qual. Beats: 0
Rev. Trend: 89.0%
Qual. Beats: 0
Warnings
No concerns identified
Tailwinds
Seasonality 10.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Barclays PLC (NYSE: BCS) is a London-headquartered global financial services company founded in 1690, making it one of the oldest banking institutions in the UK. It operates through five main segments: Barclays UK, Barclays UK Corporate Bank, Barclays Private Bank and Wealth Management, Barclays Investment Bank, and Barclays US Consumer Bank. The company offers a broad range of services including retail banking (current accounts, savings, mortgages, credit cards, and loans), wholesale and investment banking, wealth and investment management, and securities dealing. As a diversified bank, Barclays generates revenue across both consumer-facing and corporate/institutional lines, and trades on the NYSE as an American Depositary Receipt (ADR), allowing US investors to hold shares in the UK-domiciled company.
- UK net interest margins compress as BoE cuts rates
- Investment Banking revenue rises on FICC and advisory recovery
- US credit card losses climb as borrower delinquencies worsen
| Net Income: 7.23b TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.00 > 0.02 and ΔFCF/TA -0.82 > 1.0 |
| NWC/Revenue: -858.0% < 20% (prev -780.1%; Δ -77.85% < -1%) |
| CFO/TA -0.00 > 3% & CFO -6.21b > Net Income 7.23b |
| Net Debt (-290b) to EBITDA (11.0b): -26.41 < 3 |
| Current Ratio: 0.64 > 1.5 & < 3 |
| Outstanding Shares: last quarter (3.43b) vs 12m ago -4.11% < -2% |
| Gross Margin: 91.39% > 18% (prev 92.22%; Δ -0.83% > 0.5%) |
| Asset Turnover: 1.74% > 50% (prev 1.69%; Δ 0.04% > 0%) |
| Interest Coverage Ratio: 0.42 > 6 (EBIT TTM 9.21b / Interest Expense TTM 21.7b) |
| A: -0.14 (Total Current Assets 427b - Total Current Liabilities 672b) / Total Assets 1695b |
| B: 0.03 (Retained Earnings 58.8b / Total Assets 1695b) |
| C: 0.01 (EBIT TTM 9.21b / Avg Total Assets 1644b) |
| D: 0.05 (Book Value of Equity 76.7b / Total Liabilities 1618b) |
| Altman-Z'' = -0.75 = B |
As of July 14, 2026, the stock is trading at USD 27.29 with a total of 3,811,871 shares traded. Over the past week, the price has changed by -3.94%, over one month by +6.44%, over three months by +14.52% and over the past year by +49.37%.
Current recommended Stop Loss: 26.00 (which is 4.7% or 2 ATR below the current price).
Barclays has received a consensus analysts rating of 4.00. Therefore, it is recommended to buy BCS.
- StrongBuy: 1
- Buy: 0
- Hold: 1
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 29.2 | 7% |
Market Cap GBP = 69.2b (92.7b USD * 0.7474 USD.GBP)
P/E Trailing = 12.0
P/E Forward = 10.0806
P/S = 3.42
P/B = 0.9155
P/EG = 1.6809
Revenue TTM = 28.6b GBP
EBIT TTM = 9.21b GBP
EBITDA TTM = 11.0b GBP
Long Term Debt = 76.7b GBP (from longTermDebt, last fiscal year)
Short Term Debt = 73.1b GBP (from shortTermDebt, last fiscal year)
Debt = 137b GBP (from shortLongTermDebtTotal, last quarter)
Net Debt = -290b GBP (calculated: Debt 137b - CCE 426b)
Enterprise Value = 69.2b GBP (floored to Market Cap, CCE > MCap+Debt)
Interest Coverage Ratio = 0.42 (Ebit TTM 9.21b / Interest Expense TTM 21.7b)
EV/FCF = -8.58x (Enterprise Value 69.2b / FCF TTM -8.07b)
FCF Yield = -11.65% (FCF TTM -8.07b / Enterprise Value 69.2b)
FCF Margin = -28.26% (FCF TTM -8.07b / Revenue TTM 28.6b)
Net Margin = 25.33% (Net Income TTM 7.23b / Revenue TTM 28.6b)
Gross Margin = 91.39% ((Revenue TTM 28.6b - Cost of Revenue TTM 2.46b) / Revenue TTM)
Gross Margin QoQ = 89.68% (prev 92.30%)
Tobins Q-Ratio = 0.04 (Enterprise Value 69.2b / Total Assets 1695b)
Interest Expense / Debt = 15.85% (Interest Expense 21.7b / Debt 137b)
Taxrate = 21.04% (1.94b / 9.21b)
NOPAT = 7.27b (EBIT 9.21b * (1 - 21.04%))
Current Ratio = 0.64 (Total Current Assets 427b / Total Current Liabilities 672b)
Debt / Equity = 1.78 (Debt 137b / totalStockholderEquity, last quarter 76.7b)
Debt / EBITDA = -26.41 (Net Debt -290b / EBITDA 11.0b)
Debt / FCF = 35.88 (negative FCF - burning cash) (Net Debt -290b / FCF TTM -8.07b)
Total Stockholder Equity = 76.7b (last 4 quarters mean from totalStockholderEquity)
RoA = 0.44% (Net Income 7.23b / Total Assets 1695b)
RoE = 9.43% (Net Income TTM 7.23b / Total Stockholder Equity 76.7b)
RoCE = 6.00% (EBIT 9.21b / Capital Employed (Equity 76.7b + L.T.Debt 76.7b))
RoIC = 0.66% (NOPAT 7.27b / Invested Capital 1095b)
WACC = 11.68% (E(69.2b)/V(206b) * Re(10.04%) + D(137b)/V(206b) * Rd(15.85%) * (1-Tc(0.21)))
Discount Rate = 10.04% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -55.51 | Cagr: -48.23%
[DCF] Fair Price = unknown (Cash Flow -8.07b)
EPS Correlation: 74.78 | EPS CAGR: 11.95% | SUE: 0.41 | # QB: 0
Revenue Correlation: 88.96 | Revenue CAGR: 5.05% | SUE: 0.00 | # QB: 0
EPS current Quarter (2026-06-30): EPS=0.87 | Chg30d=+6.00% | Revisions=+25% | Analysts=1
EPS next Quarter (2026-09-30): EPS=0.74 | Chg30d=+2.73% | Revisions=+25% | Analysts=1
EPS current Year (2026-12-31): EPS=2.82 | Chg30d=-0.17% | Revisions=+0% | GrowthEPS=+21.4% | GrowthRev=+6.7%
EPS next Year (2027-12-31): EPS=3.40 | Chg30d=+0.36% | Revisions=+0% | GrowthEPS=+20.3% | GrowthRev=+4.9%
[Analyst] Revisions Ratio: +22% (up=4, down=2)